- Home
- ZNTL vs NCV Comparison
ZNTL vs NCV Comparison
Compare ZNTL & NCV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZNTL
- NCV
- Stock Information
- Founded
- ZNTL 2014
- NCV 2003
- Country
- ZNTL United States
- NCV United States
- Employees
- ZNTL N/A
- NCV N/A
- Industry
- ZNTL Biotechnology: Pharmaceutical Preparations
- NCV Finance Companies
- Sector
- ZNTL Health Care
- NCV Finance
- Exchange
- ZNTL Nasdaq
- NCV Nasdaq
- Market Cap
- ZNTL 105.8M
- NCV 317.4M
- IPO Year
- ZNTL 2020
- NCV N/A
- Fundamental
- Price
- ZNTL $1.33
- NCV $14.16
- Analyst Decision
- ZNTL Buy
- NCV
- Analyst Count
- ZNTL 7
- NCV 0
- Target Price
- ZNTL $8.60
- NCV N/A
- AVG Volume (30 Days)
- ZNTL 1.4M
- NCV 405.1K
- Earning Date
- ZNTL 08-08-2025
- NCV 01-01-0001
- Dividend Yield
- ZNTL N/A
- NCV 12.48%
- EPS Growth
- ZNTL N/A
- NCV N/A
- EPS
- ZNTL N/A
- NCV N/A
- Revenue
- ZNTL $26,865,000.00
- NCV N/A
- Revenue This Year
- ZNTL N/A
- NCV N/A
- Revenue Next Year
- ZNTL N/A
- NCV N/A
- P/E Ratio
- ZNTL N/A
- NCV N/A
- Revenue Growth
- ZNTL N/A
- NCV N/A
- 52 Week Low
- ZNTL $1.01
- NCV $2.84
- 52 Week High
- ZNTL $5.44
- NCV $3.59
- Technical
- Relative Strength Index (RSI)
- ZNTL 50.91
- NCV 62.28
- Support Level
- ZNTL $1.15
- NCV $14.06
- Resistance Level
- ZNTL $1.38
- NCV $14.35
- Average True Range (ATR)
- ZNTL 0.10
- NCV 0.14
- MACD
- ZNTL 0.01
- NCV 0.01
- Stochastic Oscillator
- ZNTL 75.00
- NCV 76.22
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
About NCV Virtus Convertible & Income Fund of Beneficial Interest
Virtus Convertible & Income Fund is a diversified, closed-end management investment company. Its investment objective is to provide total return through a combination of capital appreciation and high current income. It intends to achieve the objective by investing in a portfolio of domestic convertible securities and non-convertible income-producing securities. Its portfolio of investments includes Software, the Internet, the Commercial Services sector in the form of Convertible Bonds and Notes, and Media, Oil, Gas & Consumable Fuels, and Entertainment sector in the form of Corporate Bonds and Notes.